Search

everythinglearnresearchcommunity

for

Search:↓

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

The uniform density approach in hair restoration is less noticeable in situations like wind or exercise.

Scalp reduction can effectively treat male pattern baldness, with most patients satisfied and few complications.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Antioxidants improved hair growth in alopecia areata patients regardless of disease duration.

Non-ablative Er:YAG-laser treatment helps improve life quality for menopausal women with hair loss.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Dr. Norwood's analysis highlights the need for careful patient selection and strategic hair transplant design to create a natural-looking hair density.

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Fingerprints form uniquely before birth due to specific genetic pathways and local signals.

PRP injections can effectively and safely treat alopecia areata.

The 10% Angiopteris evecta hair tonic is stable, promotes hair growth, and is safe.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The gene LRRC15 is more active in balding areas of the scalp compared to non-balding areas.

Pathologic tissues have more soluble proteins than normal tissues.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Platelet-rich plasma (PRP) is a promising treatment for hair loss, believed to extend the life cycle of hair follicles and prevent their shrinkage.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

The document concludes that hair transplant methods are often selected for provider convenience over patient benefit, highlighting the need for less invasive techniques and careful physician involvement for better results.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Hair transplantation is highly effective with careful technique and attention to patient needs.

Alopecia patients in the UK want more empathy and better care from healthcare providers, including more GP training on alopecia and improved care pathways.

Male hair loss is caused by inactive hair follicle stem cells.

Hair transplantation techniques have improved over 12 years, with follicular unit grafting providing more natural results and potential future advances in automation and genetics.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.